Sarah James
Stock Analyst at Cantor Fitzgerald
(1.93)
# 3,148
Out of 4,964 analysts
285
Total ratings
34.55%
Success rate
-8.49%
Average return
Main Sectors:
Stocks Rated by Sarah James
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Reiterates: Overweight | $440 | $303.09 | +45.17% | 18 | Aug 26, 2025 | |
| UHS Universal Health Services | Reiterates: Neutral | $227 | $181.28 | +25.22% | 25 | Aug 26, 2025 | |
| THC Tenet Healthcare | Reiterates: Overweight | $190 | $182.52 | +4.10% | 21 | Aug 26, 2025 | |
| MOH Molina Healthcare | Reiterates: Neutral | $210 | $179.50 | +16.99% | 13 | Aug 26, 2025 | |
| HCA HCA Healthcare | Reiterates: Overweight | $444 | $404.54 | +9.75% | 20 | Aug 26, 2025 | |
| CVS CVS Health | Reiterates: Overweight | $78 | $72.53 | +7.54% | 15 | Aug 26, 2025 | |
| CNC Centene | Reiterates: Neutral | $38 | $28.69 | +32.47% | 15 | Aug 26, 2025 | |
| CI The Cigna Group | Reiterates: Overweight | $365 | $301.50 | +21.06% | 22 | Aug 26, 2025 | |
| PGNY Progyny | Maintains: Overweight | $26 → $28 | $23.32 | +20.07% | 15 | Aug 8, 2025 | |
| HCAT Health Catalyst | Downgrades: Neutral | $9 → $4 | $3.58 | +11.73% | 7 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $290 | $301.80 | -3.91% | 21 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $485 | $316.25 | +53.36% | 20 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $29 | $20.18 | +43.74% | 6 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $15 | $6.29 | +138.47% | 11 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $52 | $22.99 | +126.19% | 13 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $43 | $22.69 | +89.51% | 12 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $5 | $1.58 | +216.46% | 8 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $10 | $7.70 | +29.87% | 2 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $133 | $136.65 | -2.67% | 6 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $42 | $26.05 | +61.23% | 3 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $5 | $3.94 | +26.90% | 2 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $7.95 | -37.11% | 2 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $16.28 | +28.99% | 3 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $39 | $71.45 | -45.42% | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $193 | $69.01 | +179.67% | 2 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $2.78 | - | 2 | Mar 1, 2017 |
UnitedHealth Group
Aug 26, 2025
Reiterates: Overweight
Price Target: $440
Current: $303.09
Upside: +45.17%
Universal Health Services
Aug 26, 2025
Reiterates: Neutral
Price Target: $227
Current: $181.28
Upside: +25.22%
Tenet Healthcare
Aug 26, 2025
Reiterates: Overweight
Price Target: $190
Current: $182.52
Upside: +4.10%
Molina Healthcare
Aug 26, 2025
Reiterates: Neutral
Price Target: $210
Current: $179.50
Upside: +16.99%
HCA Healthcare
Aug 26, 2025
Reiterates: Overweight
Price Target: $444
Current: $404.54
Upside: +9.75%
CVS Health
Aug 26, 2025
Reiterates: Overweight
Price Target: $78
Current: $72.53
Upside: +7.54%
Centene
Aug 26, 2025
Reiterates: Neutral
Price Target: $38
Current: $28.69
Upside: +32.47%
The Cigna Group
Aug 26, 2025
Reiterates: Overweight
Price Target: $365
Current: $301.50
Upside: +21.06%
Progyny
Aug 8, 2025
Maintains: Overweight
Price Target: $26 → $28
Current: $23.32
Upside: +20.07%
Health Catalyst
Aug 8, 2025
Downgrades: Neutral
Price Target: $9 → $4
Current: $3.58
Upside: +11.73%
May 1, 2025
Reiterates: Neutral
Price Target: $290
Current: $301.80
Upside: -3.91%
Apr 23, 2025
Reiterates: Overweight
Price Target: $485
Current: $316.25
Upside: +53.36%
Mar 11, 2025
Maintains: Overweight
Price Target: $20 → $29
Current: $20.18
Upside: +43.74%
Mar 11, 2025
Reiterates: Overweight
Price Target: $15
Current: $6.29
Upside: +138.47%
Dec 10, 2024
Reiterates: Neutral
Price Target: $52
Current: $22.99
Upside: +126.19%
Oct 4, 2024
Reiterates: Overweight
Price Target: $43
Current: $22.69
Upside: +89.51%
Sep 20, 2024
Reiterates: Overweight
Price Target: $5
Current: $1.58
Upside: +216.46%
Aug 20, 2024
Reiterates: Overweight
Price Target: $10
Current: $7.70
Upside: +29.87%
Mar 6, 2024
Initiates: Equal-Weight
Price Target: $133
Current: $136.65
Upside: -2.67%
Aug 22, 2023
Reiterates: Overweight
Price Target: $42
Current: $26.05
Upside: +61.23%
Sep 15, 2022
Maintains: Equal-Weight
Price Target: $6 → $5
Current: $3.94
Upside: +26.90%
Aug 19, 2022
Maintains: Overweight
Price Target: $7 → $5
Current: $7.95
Upside: -37.11%
Aug 8, 2022
Maintains: Overweight
Price Target: $14 → $21
Current: $16.28
Upside: +28.99%
Aug 12, 2021
Initiates: Overweight
Price Target: $39
Current: $71.45
Upside: -45.42%
Sep 15, 2017
Upgrades: Overweight
Price Target: $193
Current: $69.01
Upside: +179.67%
Mar 1, 2017
Downgrades: Underweight
Price Target: n/a
Current: $2.78
Upside: -